4//SEC Filing
Kerr Giles Francis Bertram 4
Accession 0001104659-19-039323
CIK 0001621227other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:00 PM ET
Size
5.5 KB
Accession
0001104659-19-039323
Insider Transaction Report
Form 4
Kerr Giles Francis Bertram
Director
Transactions
- Award
Option to purchase Ordinary Shares
2019-07-02+124,000→ 124,000 totalExercise: $0.61From: 2020-07-02Exp: 2029-07-02→ Ordinary Shares (124,000 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.48 based on an exchange rate of $U.S. 1.2638 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001689112
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:00 PM ET
- Size
- 5.5 KB